Drugs / HS_SW01 cells injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07551895 | Apr 2026 → Dec 2027 expected | primary ovarian failure | Shenzhen Huishan Biotechnology Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HS_SW01 cells injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07551895 ↗ |
| Modality | Cell therapy | “human umbilical cord mesenchymal stem cell injection” NCT07551895 ↗ |
| Route | Intravenous | “given by intravenous infusion” NCT07551895 ↗ |